Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes
US10632154B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2016 |
| Grant date | Apr 28, 2020 |
| Priority date | — |
| Expiry date | Nov 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si-HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.